Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Redhill Biophrma ADR (RDHL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 211,849
  • Shares Outstanding, K 21,270
  • Annual Sales, $ 4,010 K
  • Annual Income, $ -45,540 K
  • 36-Month Beta 0.78
  • Price/Sales 54.95
  • Price/Cash Flow N/A
  • Price/Book 6.07

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.54 +32.10%
on 06/22/18
11.49 -13.32%
on 07/16/18
+1.79 (+21.91%)
since 06/20/18
3-Month
4.70 +111.91%
on 05/02/18
11.49 -13.32%
on 07/16/18
+4.95 (+98.80%)
since 04/20/18
52-Week
4.30 +131.63%
on 12/06/17
11.49 -13.32%
on 07/16/18
+0.49 (+5.17%)
since 07/20/17

Most Recent Stories

More News
RedHill Gets Two New Patents for Crohn's Disease Candidate

RedHill Biopharma (RDHL) announces allowances of two new patents from the United States Patent and Trademark Office and the European Patent Office for its Crohn's disease candidate, RHB-104.

RDHL : 9.96 (-3.77%)
CRSP : 58.35 (-0.07%)
TARO : 112.94 (-0.72%)
CCXI : 12.32 (+0.20%)
RedHill Biopharma (RDHL) Catches Eye: Stock Jumps 5.4%

RedHill Biopharma (RDHL) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

RDHL : 9.96 (-3.77%)
TARO : 112.94 (-0.72%)
RedHill Biopharma Announces Allowance of Two New RHB-104 Patents Ahead of Top-Line Phase III Results for Crohn's Disease

-- RedHill has received Notices of Allowance for two new patents covering RHB-104 in the U.S. and Europe which are expected to be valid until at least 2029, once granted

RDHL : 9.96 (-3.77%)
Jaguar Health (NASDAQ: JAGX) Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product

RedHill (NASDAQ: RDHL) has been granted the exclusive right to co-promote Mytesi® (crofelemer 125 mg delayed-release tablets) to certain gastroenterologists and primary care physicians for the approved...

RDHL : 9.96 (-3.77%)
JAGX : 1.16 (+2.65%)
RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi(R)

-- Mytesi is an FDA-approved anti-diarrheal prescription drug indicated for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on anti-retroviral therapy (ART)

RDHL : 9.96 (-3.77%)
JAGX : 1.16 (+2.65%)
RedHill Biopharma (RDHL): Moving Average Crossover Alert

RedHill Biopharma Ltd. (RDHL) is looking like an interesting pick from a technical perspective

RDHL : 9.96 (-3.77%)
Small Drugmakers Edging Out the Bigshots: 7 Stocks to Buy

Smaller drugmakers are having a relatively better year than their larger counterparts. Here are seven stocks to buy.

RDHL : 9.96 (-3.77%)
ACER : 20.25 (-0.49%)
JAZZ : 176.49 (-0.35%)
COOL : 19.26 (-5.91%)
ACRX : 2.95 (unch)
ENTA : 122.34 (-0.64%)
TARO : 112.94 (-0.72%)
RedHill Biopharma (RDHL) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in RedHill Biopharma Ltd. (RDHL)

RDHL : 9.96 (-3.77%)
Factors of Influence in 2018, Key Indicators and Opportunity within BiondVax Pharmaceuticals, MercadoLibre, 1-800 FLOWERS.COM, Redhill Biopharma, Mountain Province Diamonds, and Rhythm Pharmaceuticals -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BiondVax Pharmaceuticals, Ltd....

RDHL : 9.96 (-3.77%)
MELI : 373.46 (-0.31%)
FLWS : 13.50 (+5.47%)
MPVD : 2.45 (unch)
RYTM : 31.50 (-3.88%)
MDM : 5.10 (+3.45%)
BVXV : 6.35 (unch)
RedHill Biopharma to Present Positive Phase II Results of BEKINDA(R) for IBS-D at Digestive Disease Week 2018

RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization...

RDHL : 9.96 (-3.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade RDHL with:

Business Summary

Redhill Biopharma Ltd, is an Israel-based specialty biopharmaceutical company. The Company focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. It offers...

See More

Key Turning Points

2nd Resistance Point 11.38
1st Resistance Point 10.67
Last Price 9.96
1st Support Level 9.56
2nd Support Level 9.16

See More

52-Week High 11.49
Last Price 9.96
Fibonacci 61.8% 8.74
Fibonacci 50% 7.89
Fibonacci 38.2% 7.05
52-Week Low 4.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar